Brief: Pediapharm receives Health Canada approval for Cuvposa
Nov 1 (Reuters) - Pediapharm Inc PDP.V
* Pediapharm receives Health Canada approval for Cuvposa(tm)
Source text for Eikon: ID:nCCNHp1lBa
Further company coverage: PDP.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million